Immunoprecise Antibodies Ltd
NASDAQ:HYFT

Watchlist Manager
Immunoprecise Antibodies Ltd Logo
Immunoprecise Antibodies Ltd
NASDAQ:HYFT
Watchlist
Price: 1.84 USD -8.46%
Market Cap: $84.9m

Net Margin

-201.5%
Current
Declining
by 38.5%
vs 3-y average of -163%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-201.5%
=
Net Income
CA$-29.8m
/
Revenue
CA$20.4m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-201.5%
=
Net Income
$-29.8m
/
Revenue
CA$20.4m

Peer Comparison

Country Company Market Cap Net
Margin
US
Immunoprecise Antibodies Ltd
NASDAQ:HYFT
92.8m USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
223.6B USD
Loading...
US
Danaher Corp
NYSE:DHR
155.8B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
82.4T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.3B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.9B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
37.5B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.3B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.6B EUR
Loading...

Market Distribution

Lower than 88% of companies in the United States of America
Percentile
12th
Based on 15 072 companies
12th percentile
-201.5%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Immunoprecise Antibodies Ltd
Glance View

ImmunoPrecise Antibodies Ltd. is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The company is headquartered in Austin, Texas. The company is advancing Bio-Native AI at the intersection of biology and computation. Its LENSai and HYFT platforms enable large-scale reasoning across sequence, structure, function, and scientific literature, powering workflows across drug discovery, diagnostics, vaccine design, and molecular systems biology. The core of its operations encompasses a diverse suite of proprietary technologies that aid in the exploration, discovery, and development of novel drugs and biologics. Integrated within its wet lab infrastructure is a diverse array of in silico technologies. As an end-to-end service provider of antibody discovery and development, its computational methodologies allow the Company to perform detailed and comprehensive evaluations across various stages of biologic discovery and development. The company is involved in antibody characterization studies, which encompass affinity measurements, epitope landscape profiling, and others.

HYFT Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-201.5%
=
Net Income
CA$-29.8m
/
Revenue
CA$20.4m
What is Immunoprecise Antibodies Ltd's current Net Margin?

The current Net Margin for Immunoprecise Antibodies Ltd is -201.5%, which is below its 3-year median of -163%.

How has Net Margin changed over time?

Over the last 3 years, Immunoprecise Antibodies Ltd’s Net Margin has decreased from -172.3% to -201.5%. During this period, it reached a low of -279.2% on Jan 31, 2025 and a high of -80.9% on Jan 31, 2024.

Back to Top